Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

 

2019 ASH Review of Frontline CLL: Can We Improve CIT by Adding a Novel Agent to the Backbone? How Can Next Generation BTKis Distinguish Themselves from Ibrutinib?

April 14, 2020

0 Comments
Login to view comments. Click here to Login
Leukemia